The present invention relates to a device for regulating the flow of blood in blood vessels.
The blood system, and in particular the venal blood system of the legs and arms are provided with valves, at predetermined positions, which ensure that blood cannot flow back along the system in the direction from which it has just been pumped, to only be displaced in the direction of the heart.
In the arms and legs, there is a deep and a surface venal system.
Due to various causes, thrombosis can occur in especially the deep venal system. Following thinning of the blood, passage of the blood through the system is often again possible, but in this case the valves do not effectively close off the system and often leak. This causes an increased venal blood pressure in the direction of the ankles, which leads to many problems, such as varicose veins and the infamous “open leg”. This type of complaint is wide spread among people who spend a vast majority of their working hours in a standing position, for instance surgeons.
The surface venal system of the leg is weaker than the deep system, and has the tendency to spontaneously widen, whereby the valves no longer function effectively, leading to varicose veins, which, apart from being highly unattractive, are also very painful. Major surgery is often required to deal with these blood vessel valve problems.
For example varicose veins are presently surgically operated on, by either closing off the vein, which leads to a reduced blood flow capacity and extra pressure on surrounding blood vessels in order to ensure blood supply, or by completely removing the varicose veins, which leads to the same problem.
An object of the present invention is to obviate one or more of these problems.
According to a first aspect, the present invention provides a device for regulating the flow of blood in blood vessels, comprising one or more flow stoppage elements, each comprising:
By introducing a synthetic device which acts as a valve, the blood flow is now able to be regulated in substantially the normal manner.
The device preferably further comprises:
When occupying the blood flow stoppage configuration, the flow stoppage element encloses a temporary blood storage area between its open proximal end and the closed distal end. In this way between heartbeats, which force the blood through the venal system, any blood flowing in the opposite direction to the blood stream opens the proximal end of the stoppage element thereby forcing the sidewalls apart to enter the temporary blood storage area, instead of passing through the device to leak back into the blood vessel in the direction from where it has just been pumped. Since opening of the blood flow stoppage element effectively closes off the blood vessel, a very effective valve is provided.
The flow stoppage element is preferably mounted on a support having such a form as to pass within a blood vessel. This provides extra stability.
Further, the support frame comprises a resilient wire and is biased toward an unrolled configuration.
The stoppage element is preferably substantially conical in shape when occupying the blood flow stoppage configuration, the closed distal end being synonymous with the tip of the cone and the proximal end opening being synonymous with the flared base of the cone. This yields a highly effective valve working.
The support is preferably adjustable between an introducing form, wherein the device is suitable for introducing into a blood vessel, and an expanded form suitable for supporting the stoppage element within a blood vessel at the desired working location thereof, and most preferably has such a form as to have substantially the same length when occupying its introducing form as when occupying its expanded form. Accordingly the device can be effectively introduced to a pre-desired location within a blood vessel, whereafter it is expandable to take up its working form. Since the support has substantially the same length when in its introducing form as in its expanded form, the stoppage elements remain effectively supported, and any damage ensuing from alteration of the length of the support within the blood system is effectively obviated.
In order to yield a very effective valve working, the support preferably comprises substantially separate frame sections for each of the one or more fluid passage stoppage elements.
According to another aspect of the present invention, there is provided a support for a fluid stoppage element as referred to above.
According to yet a further aspect of the present invention there is provided a method for regulating the flow of blood in the blood stream comprising introducing the above device into a blood vessel, so that the distal end thereof is arranged downstream from the proximal end, wherein the proximal end opening is closed by the pressure of blood flowing through the device, as blood is pumped through the system by the heart, wherein blood flowing in the opposite direction to which it is pumped between beats, flows into the proximal end of the device, which is subsequently thereby opened to force the sidewalls of the device against the blood vessel walls, thereby closing off the passage of blood in the blood vessel, wherein blood is trapped in the temporary blood storage area enclosed by the sidewalls of the device before a subsequent volume of blood being pumped through the device claps said sidewalls shut, thereby expelling blood out of the temporary storage area and further through the system.
The introducer preferably comprises an elongated sliding member which is advanceable by a physician to forcibly displace the valve prosthesis from the hollow distal portion of said introducer into the blood vessel.
The present invention will now be further clarified by way of the following specific description, which refers to
A device 1 (
Blood flow stoppage elements 6, having the form of flexible hollow cones, are each supported on a substantially triangular frame section 8 of a support 10, see also
The valve elements 6 have an inner wall 12 and an outer wall 14 extending from a proximal end (2) opening 16 in the “flared” configuration to join together and terminate in the form of a pointed end section 17 at the distal end 4.
The support 10 is preferably made of a continuous length of memory metal, having, as shown in
As shown in
In such a position the device 1 is easily introduced into a blood vessel.
On being placed at its desired position within the blood system, the device, once the memory metal has achieved a particular predetermined temperature, will expand in order to assume its working form as shown in
In order to ensure biocompatibility, the support and blood stoppage elements are made of biocompatible material, whereby the blood stoppage elements are most preferably made of polytetrafluoroethylene (PTFE).
The device 1 is folded up into its introducing form, as shown in
On assuming its working configuration as shown in
Blood is pumped through the blood vessel 20 (
When actively pumped through the system, blood is forced through the device 1 through the distal end 4 and out of the proximal end 2 (
In this position (
Between heartbeats, blood having just passed through the proximal opening 2 of the device 1, can flow back down the blood vessel 20. On doing so, it forces the inner walls 12 away from the outer walls 14 of these elements 6 at the proximal end 2 of the device 1 to create the opening 16 leading into a temporary blood storage area 22. Since the inner walls 12 and the outer walls 14 are joined together at the distal end 4 of the device, the temporary blood storage area 22 is effected in each blood stoppage element 6 at this phase (
During the next pulse of blood through the device 1 from the distal end 4, the inner walls 12 are forced against the outer walls 14 of the stoppage elements 6, thus forcing the blood temporarily stored therein out of the blood stoppage elements 6 and effecting the open channel to enable blood through flow.
Number | Date | Country | Kind |
---|---|---|---|
1004827 | Dec 1996 | NL | national |
This application is a continuation of U.S. application Ser. No. 09/630,403, filed Aug. 1, 2000 (issued as U.S. Pat. No. 6,605,112), which is a continuation of U.S. application Ser. No. 08/992,350 (issued as U.S. Pat. No. 6,287,334), filed on Dec. 17, 1997, which claims priority from Netherlands Application No. 1004827, filed Dec. 18, 1996, each of the aforementioned applications being incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
4291420 | Reul | Sep 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4470157 | Love | Sep 1984 | A |
4787901 | Baykut | Nov 1988 | A |
4994077 | Dobben | Feb 1991 | A |
5141491 | Bowald | Aug 1992 | A |
5327774 | Nguyen et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5411552 | Andersen et al. | May 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5607465 | Camilli | Mar 1997 | A |
5713953 | Vallana et al. | Feb 1998 | A |
5735859 | Fischell et al. | Apr 1998 | A |
5741326 | Solovay | Apr 1998 | A |
5741333 | Frid | Apr 1998 | A |
5800506 | Perouse | Sep 1998 | A |
5824061 | Quijano et al. | Oct 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6110201 | Quijano et al. | Aug 2000 | A |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6241763 | Drasler et al. | Jun 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6315793 | Bokros et al. | Nov 2001 | B1 |
20010010017 | Letac et al. | Jul 2001 | A1 |
Number | Date | Country |
---|---|---|
1932817 | Jan 1970 | DE |
19532846 | Mar 1997 | DE |
0 155 245 | Mar 1985 | EP |
0667133 | Aug 1995 | EP |
1477643 | Jun 1977 | GB |
2 056 023 | Mar 1981 | GB |
1271508 | Nov 1986 | RU |
WO 9619159 | Jun 1996 | WO |
Number | Date | Country | |
---|---|---|---|
20040015230 A1 | Jan 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09630403 | Aug 2000 | US |
Child | 10619725 | US | |
Parent | 08992350 | Dec 1997 | US |
Child | 09630403 | US |